Patient Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chronic Kidney Failure Therapy
Research on chronic kidney failure therapy detailed by scientists at Duke University, Division of Nephrology
January 14th, 2007
A new study, "Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans," is now available. "The Medicare Part D prescription drug benefit may facilitate provision of medications by subsidizing drug costs. However, beneficiaries with higher drug utilization may face higher out-of-pocket (OOP) costs under the benefit's "doughnut hole" provisions that substantially increase beneficiary cost-sharing," researchers in the United States report. "The Medicare Current Beneficiary Survey Cost and Use data for 1997 through 2001 were used to estimate the impact of the standard Part D benefit on drug expenditures. The...
Source: Patient Care Law Weekly (2007-01-14)
|
